Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 118Active not recruiting 42Not yet recruiting 18Completed 16Terminated 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 41Breast Neoplasms 31Neoplasms 28Neoplasm Metastasis 23Melanoma 20Leukemia, Myeloid, Acute 20Prostatic Neoplasms 19Colorectal Neoplasms 17Multiple Myeloma 16Lung Neoplasms 16Recurrence 13Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 12Ovarian Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Uterine Cervical Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Glioma 7Brain Neoplasms 7Solid Tumor 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

pembrolizumab 1futibatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Endometrial Neoplasms × 90 days × Clear all
NCT01164150 2026-04-13

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Cancer Trials Ireland

Phase 2 Terminated
92 enrolled
Gynecologic

Radiation Injuries, Endometrial Neoplasms

NCT05180474 2026-04-13

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Genmab

Phase 1/2 Terminated
179 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05036681 2026-03-27

A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

M.D. Anderson Cancer Center

Phase 2 Terminated
9 enrolled 10 charts
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡